These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17505915)

  • 1. Newborn screening for cystic fibrosis: techniques and strategies.
    Wilcken B
    J Inherit Metab Dis; 2007 Aug; 30(4):537-43. PubMed ID: 17505915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
    Ranieri E; Lewis BD; Gerace RL; Ryall RG; Morris CP; Nelson PV; Carey WF; Robertson EF
    BMJ; 1994 Jun; 308(6942):1469-72. PubMed ID: 8019280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for cystic fibrosis.
    Hayes D
    South Med J; 2006 Apr; 99(4):403. PubMed ID: 16634253
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.
    Larsen J; Campbell S; Faragher EB; Götz M; Eichler I; Waldherr S; Dobianer K; Spona J
    Eur J Pediatr; 1994 Aug; 153(8):569-73. PubMed ID: 7957403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
    Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
    BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for cystic fibrosis.
    Rock MJ
    Clin Chest Med; 2007 Jun; 28(2):297-305. PubMed ID: 17467549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening.
    Kammesheidt A; Kharrazi M; Graham S; Young S; Pearl M; Dunlop C; Keiles S
    Genet Med; 2006 Sep; 8(9):557-62. PubMed ID: 16980811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
    Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
    Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening.
    Baker MW; Groose M; Hoffman G; Rock M; Levy H; Farrell PM
    J Cyst Fibros; 2011 Jul; 10(4):278-81. PubMed ID: 21388895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for cystic fibrosis: can one algorithm fit all?
    Caggana M
    Expert Rev Mol Diagn; 2017 Mar; 17(3):205-207. PubMed ID: 28127999
    [No Abstract]   [Full Text] [Related]  

  • 16. Newborn screening methods for cystic fibrosis.
    Wilcken B; Wiley V
    Paediatr Respir Rev; 2003 Dec; 4(4):272-7. PubMed ID: 14629948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
    Wells J; Rosenberg M; Hoffman G; Anstead M; Farrell PM
    Pediatrics; 2012 Feb; 129(2):e339-47. PubMed ID: 22291119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity.
    Castellani C; Bonizzato A; Cabrini G; Mastella G
    Acta Paediatr; 1997 May; 86(5):497-502. PubMed ID: 9183489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.